Perrigo Company plc (NYSE:PRGO – Get Free Report) declared a quarterly dividend on Thursday, February 19th. Shareholders of record on Monday, March 2nd will be paid a dividend of 0.29 per share on Tuesday, March 24th. This represents a c) annualized dividend and a yield of 7.8%. The ex-dividend date of this dividend is Monday, March 2nd.
Perrigo has raised its dividend by an average of 0.1%per year over the last three years and has increased its dividend annually for the last 23 consecutive years. Perrigo has a dividend payout ratio of 35.5% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Perrigo to earn $3.06 per share next year, which means the company should continue to be able to cover its $1.16 annual dividend with an expected future payout ratio of 37.9%.
Perrigo Trading Up 2.2%
NYSE:PRGO opened at $14.90 on Friday. The stock has a market cap of $2.05 billion, a price-to-earnings ratio of -39.20, a PEG ratio of 1.31 and a beta of 0.39. The company has a quick ratio of 1.44, a current ratio of 2.51 and a debt-to-equity ratio of 0.81. The company’s 50 day moving average price is $14.26 and its 200-day moving average price is $17.90. Perrigo has a 52 week low of $12.17 and a 52 week high of $30.93.
Institutional Inflows and Outflows
About Perrigo
Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.
Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.
Read More
- Five stocks we like better than Perrigo
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Unlocked: Elon Musk’s Next Big IPO
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Gilder: Don’t Buy AI Stocks, Do This Instead
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.
